Correlation Between Mega Lifesciences and RS Public

Can any of the company-specific risk be diversified away by investing in both Mega Lifesciences and RS Public at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mega Lifesciences and RS Public into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mega Lifesciences Public and RS Public, you can compare the effects of market volatilities on Mega Lifesciences and RS Public and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mega Lifesciences with a short position of RS Public. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mega Lifesciences and RS Public.

Diversification Opportunities for Mega Lifesciences and RS Public

0.18

Correlation Coefficient

Mega Lifesciences  RS Public

Average diversification

The 3 months correlation between Mega and RS-R is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Mega Lifesciences Public and RS Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RS Public and Mega Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mega Lifesciences Public are associated (or correlated) with RS Public. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RS Public has no effect on the direction of Mega Lifesciences i.e., Mega Lifesciences and RS Public go up and down completely randomly.

Pair Corralation between Mega Lifesciences and RS Public

Assuming the 90 days trading horizon Mega Lifesciences Public is expected to under-perform the RS Public. But the stock apears to be less risky and, when comparing its historical volatility, Mega Lifesciences Public is 98.34 times less risky than RS Public. The stock trades about -0.06 of its potential returns per unit of risk. The RS Public is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  0.00  in RS Public on September 3, 2024 and sell it today you would earn a total of  570.00  from holding RS Public or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mega Lifesciences Public  vs.  RS Public

Mega Lifesciences Public

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mega Lifesciences Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

RS Public

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in RS Public are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, RS Public disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mega Lifesciences and RS Public

The main advantage of trading using opposite Mega Lifesciences and RS Public positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mega Lifesciences position performs unexpectedly, RS Public can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RS Public will offset losses from the drop in RS Public's long position.

The idea behind Mega Lifesciences Public and RS Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.